Texas Permanent School Fund Grows Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Texas Permanent School Fund grew its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMATGet Rating) by 2.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,962 shares of the medical instruments supplier’s stock after acquiring an additional 338 shares during the period. Texas Permanent School Fund owned about 0.06% of LeMaitre Vascular worth $636,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in LMAT. Vanguard Group Inc. boosted its holdings in shares of LeMaitre Vascular by 10.1% in the 1st quarter. Vanguard Group Inc. now owns 1,426,235 shares of the medical instruments supplier’s stock valued at $66,278,000 after acquiring an additional 130,881 shares during the last quarter. Ceredex Value Advisors LLC purchased a new stake in shares of LeMaitre Vascular in the 2nd quarter valued at $4,241,000. State of New Jersey Common Pension Fund D purchased a new stake in shares of LeMaitre Vascular in the 2nd quarter valued at $2,310,000. Values First Advisors Inc. purchased a new stake in shares of LeMaitre Vascular in the 2nd quarter valued at $1,762,000. Finally, Russell Investments Group Ltd. boosted its holdings in shares of LeMaitre Vascular by 9.5% in the 2nd quarter. Russell Investments Group Ltd. now owns 353,049 shares of the medical instruments supplier’s stock valued at $16,080,000 after acquiring an additional 30,633 shares during the last quarter. 88.45% of the stock is owned by hedge funds and other institutional investors.

LeMaitre Vascular Price Performance

LMAT opened at $45.37 on Tuesday. The firm has a fifty day moving average price of $48.08 and a 200 day moving average price of $47.60. LeMaitre Vascular, Inc. has a 1 year low of $38.32 and a 1 year high of $56.38. The stock has a market cap of $998.19 million, a P/E ratio of 47.26, a P/E/G ratio of 4.22 and a beta of 1.02.

LeMaitre Vascular Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 1st. Investors of record on Thursday, November 17th will be paid a $0.125 dividend. This represents a $0.50 annualized dividend and a dividend yield of 1.10%. The ex-dividend date of this dividend is Wednesday, November 16th. LeMaitre Vascular’s dividend payout ratio is currently 52.08%.

Wall Street Analyst Weigh In

Several analysts have recently commented on LMAT shares. Barrington Research downgraded shares of LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a report on Friday, October 28th. StockNews.com cut shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a research note on Saturday, November 5th.

LeMaitre Vascular Company Profile

(Get Rating)

LeMaitre Vascular, Inc designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system.

Further Reading

Want to see what other hedge funds are holding LMAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LeMaitre Vascular, Inc. (NASDAQ:LMATGet Rating).

Institutional Ownership by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

Receive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.